Dr Cuthbert recently spoke to ECNP press officer Tom Parkhill about RDoC, PRISM, and the future of research into the causes and treatment of mental health issues.
Click here to read the full interview.
Dr Cuthbert recently spoke to ECNP press officer Tom Parkhill about RDoC, PRISM, and the future of research into the causes and treatment of mental health issues.
Click here to read the full interview.
Mainz, Germany
The sixth PRISM² SC meeting will be held from 01 – 02 November 2023.
Madrid, Spain
The third PRISM² General Assembly and fifth Steering Commitee Meeting will be held from 23 – 24 May 2023.
Amsterdam, The Netherlands
The fourth PRISM² SC and IMI EU Midterm Review meeting will be held from 09 – 10 February 2023.
Dr Hugh Marston, head of Global CNS Diseases at Boehringer Ingelheim (BI), is the industry lead on the PRISM project. He discusses the industry perspective with ECNP Press Officer, Tom Parkhill.
Click here to read the full interview.
Mainz, Germany
The second PRISM² General Assembly and third Steering Committee Meeting will be held from 09 – 10 June 2022.
We are very happy about holding our first f2f meeting and are looking forward to see as many consortium members as possible there in person.
More information will follow soon. Check your email inbox!
PRISM² Closing in on Biomarkers. Click here to read more.
Professor Martien Kas is interviewed by Tom Parkhill (ECNP). Professor Kas is the PRISM academic project coordinator and Professor of Behavioural Neuroscience at the University of Groningen.
The interview gives some background information on PRISM and explains the goals for PRISM 2. Click here to read the full interview.
The PRISM 2 project starts today, on the 1st of April 2021. Based on the fantastic outcome, implantation, and impact of PRISM results, we received funding for 3 years to extend our research efforts into Major Depressive Disorder (MDD), explore the causality between the quantitative variation in default mode network (DMN) integrity and social dysfunction, and to intensify communication with various stakeholders.